Chidamide in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (R/R PTCL)
Condition: Relapsed or Refractory Peripheral T-cell Lymphoma Intervention: Drug: Chidamide Sponsor: Great Novel Therapeutics Biotech& Medicals Corporation Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials